This site is intended for healthcare professionals
Latest industry news
  • Home
  • /
  • News
  • /
  • 2023
  • /
  • 2
  • /
  • Celyad Oncpology change in strategy and prorities.

Celyad Oncpology change in strategy and prorities.

Read time: 1 mins
Published:3rd Feb 2023

Celyad oncology announced a strategic shift in to prioritize discovery research in areas of expertise where it can leverage the differentiated nature of its platforms.

The Company has implemented a differentiated and innovative strategy, which it believes has the potential to tackle the major current limitations of CAR T-cell therapies. This strategy includes a multiplexing approach of the short hairpin RNA (shRNA) platform, a dual CAR development of a next-generation NKG2D-based CAR, and the development of B7-H6-targeting immunotherapies.

Type: industry

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.